JPS6364402B2 - - Google Patents

Info

Publication number
JPS6364402B2
JPS6364402B2 JP10755479A JP10755479A JPS6364402B2 JP S6364402 B2 JPS6364402 B2 JP S6364402B2 JP 10755479 A JP10755479 A JP 10755479A JP 10755479 A JP10755479 A JP 10755479A JP S6364402 B2 JPS6364402 B2 JP S6364402B2
Authority
JP
Japan
Prior art keywords
aqueous solution
pantethine
soft
polyethylene glycol
soft gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP10755479A
Other languages
Japanese (ja)
Other versions
JPS5630915A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP10755479A priority Critical patent/JPS5630915A/en
Publication of JPS5630915A publication Critical patent/JPS5630915A/en
Publication of JPS6364402B2 publication Critical patent/JPS6364402B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

医薬品、殊に結晶或は粉末として得られない粘
稠性物質を主成分とする経口性医薬品の製剤化に
際して、製剤1個当りの主成分含量を出来るだけ
多くし、他の賦形剤の含量を可能な限り少くする
ためには軟カプセル剤の使用が望ましい。 かかる軟カプセル剤の剤皮は、現在ほとんどの
物がゼラチンでできている。しかしながら、ゼラ
チンを剤皮とした軟カプセルはゼラチンが水溶性
のため、水溶液成分を充填剤とする場合には剤皮
が水に溶解し、軟カプセルが破損すること等の観
点から従来使用不可能と考えられていた。従つ
て、従来のゼラチン軟カプセル剤の充填物として
は肝油、ビタミンA等に代表される油性物質だけ
が使用されている。しかるに、殊にパンテチン等
の水溶性の粘稠性物質の製剤化に際して、その濃
厚水溶液を充填したゼラチン軟カプセル剤が可能
になれば、その使用目的からしても製剤化効率か
らしても極めて望ましい。 本発明者はかかる観点から、パンテチンの水溶
液特に濃厚水溶液を充填しうるゼラチン軟カプセ
ル剤の実現について鋭意検討した結果、各種添加
剤中ポリエチレングリコールを水性充填剤に添加
した場合、特異的に安定なゼラチン軟カプセル剤
を製しうることを見い出し本発明を完成した。 本発明のゼラチン軟カプセル剤を製するにはパ
ンテチンの水溶液又は分散液にポリエチレングリ
コールを加え十分混合し、必要ならば加温して均
一化した後ゼラチン軟カプセルに充填すればよ
い。 ポリエチレングリコールの添加量はパンテチン
の水溶液又は水分散液に対し約0.5〜2倍容量を
使用すればよい。本発明に用いられるポリエチレ
ングリコールとしては通常市販されているもので
あればよく、分子量200〜6000程度のものが使用
しうるが、内容物の軟カプセルへの機械的充填を
考慮した場合には、室温で液状である分子量200
〜600の物を使用するのが望ましい。なお、本発
明の充填物には通常の軟カプセル剤の場合と同様
適当な乳化剤、PH調整剤、安定化剤等加えること
も勿論可能である。 かくして製されるポリエチレングリコールを添
加した本発明のゼラチン軟カプセル剤が他の一般
に使用される保水剤又は保湿剤の添加の場合とは
異なり特異的に安定であり、十分製剤として使用
しうるものであることは、脂質代射の改善薬とし
て著名な水溶性粘稠物質であるパンテチンの濃厚
水溶液を使用しての比較検討の結果確認された。
When formulating pharmaceuticals, especially oral pharmaceuticals whose main ingredient is a viscous substance that cannot be obtained as a crystal or powder, the content of the main ingredient per formulation should be as high as possible, and the content of other excipients should be It is desirable to use soft capsules in order to minimize the amount of Currently, most of the shells of such soft capsules are made of gelatin. However, since gelatin is water-soluble, soft capsules with gelatin shells cannot be used in the past because if an aqueous solution component is used as a filler, the shell will dissolve in water and the soft capsules will be damaged. It was thought that Therefore, only oily substances such as cod liver oil and vitamin A are used as fillers in conventional soft gelatin capsules. However, especially when formulating water-soluble viscous substances such as pantethine, if soft gelatin capsules filled with a concentrated aqueous solution of pantethine were made possible, it would be extremely useful from both the purpose of use and formulation efficiency. desirable. From this point of view, the inventors of the present invention have conducted intensive studies on the realization of soft gelatin capsules that can be filled with an aqueous solution of pantethine, particularly a concentrated aqueous solution, and have found that when polyethylene glycol among various additives is added to an aqueous filler, it is uniquely stable. The present invention was completed by discovering that soft gelatin capsules can be produced. In order to produce the soft gelatin capsules of the present invention, polyethylene glycol may be added to an aqueous solution or dispersion of pantethine, thoroughly mixed, and if necessary, heated to homogenize, and then filled into soft gelatin capsules. The amount of polyethylene glycol to be added may be about 0.5 to 2 times the volume of the aqueous solution or dispersion of pantethine. The polyethylene glycol used in the present invention may be any commercially available polyethylene glycol with a molecular weight of about 200 to 6,000, but when considering mechanical filling of the contents into soft capsules, Molecular weight 200, liquid at room temperature
It is preferable to use ~600. It is of course possible to add appropriate emulsifiers, pH adjusters, stabilizers, etc. to the filler of the present invention, as in the case of ordinary soft capsules. The soft gelatin capsules of the present invention containing polyethylene glycol produced in this manner are uniquely stable, unlike cases in which other commonly used water-retaining agents or humectants are added, and are sufficiently usable as pharmaceutical preparations. This was confirmed as a result of a comparative study using a concentrated aqueous solution of pantethine, a water-soluble viscous substance that is well-known as a lipid-injection improving drug.

【表】 表―1の結果からも明らかな如く、医薬品の保
水剤又は保湿剤として一般に使用される化合物の
うち、ポリエチレングリコールを医薬品水溶液に
添加した場合は、従来殆んど不可能と考えられて
いた水溶液成分を充填しうるゼラチン軟カプセル
剤が得られることが見い出された。 なお、保水剤又は保湿剤として使用される塩化
ナトリウム、塩化マグネシウム、明ばん等の無機
化合物についても検討した結果、これらはパンテ
チン濃厚水溶液に溶解しがたく、均一な分散が不
可能であることからして本発明の目的とするゼラ
チン軟カプセル剤の製造には使用できないことが
判明した。 実施例 1 パンテチンの60(W/V)%水溶液100mlにポリ
エチレングリコール(分子量400)100mlを加え加
温下撹拌混合する。得られた溶液の一部を約2ml
容量のゼラチン軟カプセル10個に小分け充填す
る。かくして製した軟カプセル剤を40℃、室温下
及び5℃冷却下、各々2ケ月間保存した後形状変
化を調べた結果、いずれも何ら変化が認められな
かつた。 参考例 1 パンテチンの60(W/V)%水溶液100mlにポリ
エチレングリコール(分子量400)300mlを加え加
温下撹拌混合する。以下実施例1と同様にして製
したゼラチン軟カプセル剤についての安定性を調
べた結果、全て変化は認められなかつた。 参考例 2 パンテチンの60(W/V)%水溶液100mlにグリ
セリン300mlを加え、加温下撹拌混合する。以下
実施例1と同様にして製したゼラチン軟カプセル
剤についての安定性を調べた結果、40℃及び室温
の条件下においてはカプセル剤皮が溶解し、内容
液の流出が認められ、又5℃冷却下においては剤
皮の軟化変形が認められた。 参考例 3 パンテチンの60(W/V)%水溶液100mlにプロ
ピレングリコール300mlを加え、加温下撹拌混合
する。以下実施例1と同様にして製したゼラチン
軟カプセル剤についての安定性を調べた結果、40
℃の条件下においてはカプセル剤皮が溶解し、内
容液の流出が認められ、又室温下及び5℃冷却下
においては剤皮の軟化変形が認められた。
[Table] As is clear from the results in Table 1, among the compounds commonly used as water-retaining agents or humectants for pharmaceuticals, adding polyethylene glycol to an aqueous pharmaceutical solution was previously thought to be almost impossible. It has now been found that soft gelatin capsules can be obtained which can be filled with aqueous ingredients. Furthermore, as a result of examining inorganic compounds such as sodium chloride, magnesium chloride, and alum, which are used as water-retaining agents or humectants, it was found that these were difficult to dissolve in a concentrated aqueous solution of pantethine, and uniform dispersion was impossible. It was found that this method could not be used for producing soft gelatin capsules, which is the object of the present invention. Example 1 100 ml of polyethylene glycol (molecular weight 400) was added to 100 ml of a 60 (W/V)% aqueous solution of pantethine and mixed with stirring under heating. Approximately 2 ml of the resulting solution
Divide and fill into 10 soft gelatin capsules. The thus prepared soft capsules were stored at 40° C., room temperature, and cooled at 5° C. for 2 months, respectively, and then examined for changes in shape. As a result, no changes were observed in either case. Reference Example 1 Add 300 ml of polyethylene glycol (molecular weight 400) to 100 ml of a 60 (W/V)% aqueous solution of pantethine and mix with stirring under heating. The stability of the soft gelatin capsules prepared in the same manner as in Example 1 was examined, and no changes were observed in all cases. Reference Example 2 Add 300 ml of glycerin to 100 ml of a 60 (W/V)% aqueous solution of pantethine, and mix with stirring under heating. As a result of examining the stability of soft gelatin capsules prepared in the same manner as in Example 1, it was found that the capsule skin dissolved at 40°C and room temperature, and the liquid content leaked out at 40°C. Softening and deformation of the shell was observed under cooling. Reference Example 3 Add 300 ml of propylene glycol to 100 ml of a 60 (W/V)% aqueous solution of pantethine, and mix with stirring under heating. As a result of examining the stability of gelatin soft capsules prepared in the same manner as in Example 1, it was found that 40
Under conditions of 5°C, the capsule shell dissolved and the liquid content leaked out, and at room temperature and cooling at 5°C, softening and deformation of the capsule shell was observed.

Claims (1)

【特許請求の範囲】[Claims] 1 パンテチンの水溶液又は水分散液1容量部に
0.5〜2容量部のポリエチレングリコールを均一
に混合したものを充填したゼラチン軟カプセル
剤。
1 1 volume part of an aqueous solution or dispersion of pantethine
A soft gelatin capsule filled with a uniform mixture of 0.5 to 2 parts by volume of polyethylene glycol.
JP10755479A 1979-08-23 1979-08-23 Soft gelatin capsule Granted JPS5630915A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10755479A JPS5630915A (en) 1979-08-23 1979-08-23 Soft gelatin capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10755479A JPS5630915A (en) 1979-08-23 1979-08-23 Soft gelatin capsule

Publications (2)

Publication Number Publication Date
JPS5630915A JPS5630915A (en) 1981-03-28
JPS6364402B2 true JPS6364402B2 (en) 1988-12-12

Family

ID=14462120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10755479A Granted JPS5630915A (en) 1979-08-23 1979-08-23 Soft gelatin capsule

Country Status (1)

Country Link
JP (1) JPS5630915A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002315779B2 (en) 2001-07-05 2007-03-22 Wakunaga Pharmaceutical Co.,Ltd Soft capsules

Also Published As

Publication number Publication date
JPS5630915A (en) 1981-03-28

Similar Documents

Publication Publication Date Title
JP3678745B2 (en) Gelatin capsule containing high concentration acetaminophen solution
JP4990474B2 (en) Process for the preparation of pharmaceutical compositions for use with soft gelatin formulations
US5641512A (en) Soft gelatin capsule compositions
EP0293406B1 (en) Solvent system for an ionizable pharmaceutical agent
US2580683A (en) Capsules filled with aqueous solutions and method of preparing the same
EP0591346A1 (en) Process for solubilizing difficultly soluble pharmaceutical actives
AU2002224317A1 (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
CZ210496A3 (en) Method improving solution process of difficult-to dissolve pharmaceutically active compounds
JP2013517304A (en) Pharmaceutical formulation of naproxen and its combination for softgel encapsulation
JPS6160613A (en) Heat melting antihistamine prescription
JPS63198618A (en) Encapsulation
JPS6364402B2 (en)
JPH07165561A (en) Preparation of laxative composition
JPS59101420A (en) Rectal composition containing indomethacin
KR100201907B1 (en) A softcapsule containing biphenyldimethyldicarboxylate (pmc) solution
JPS58201710A (en) Anti-inflammatory paste preparation for oral cavity
JPS6034905A (en) Pharmaceutical preparation of active substance on surface of lung
JP2003267875A (en) Ointment preparation
JPS58103316A (en) Skin of soft capsule